ADMA Biologics CEO Adam S. Grossman reports sale of $1.76 million in shares
ADMA•ADMA Biologics CEO Adam S. Grossman sold 147,000 common shares at $12 each on November 5, 2026, and exercised options for 105,000 shares at $5.40 each.
ADMA•ADMA•ADMA•ADMA Biologics CEO Adam S. Grossman sold 147,000 common shares at $12 each on November 5, 2026, and exercised options for 105,000 shares at $5.40 each.
Grossman sold 147,000 common shares at $12 each and exercised stock options for 105,000 common shares at $5.40 per share. After the transactions, he directly held 2,070,777 common shares and indirectly held 1,724,383.
